2651 - 2660 of 8823 Results
Title
Year
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 13
-
RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 45
-
RESTRICTEDTitle: Rebound symptoms following battery depletion in the NIH OCD DBS cohort: Clinical and reimbursement issuesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 5Issue #: 4Start Page: 599End Page: 604Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2011.10.004Best OA location URL: https://doaj.org/article/b024d8fe27934435bcc70ba31a037d69Citation Count: 46
-
RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
-
OPENTitle: Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 285End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6532623Citation Count: 19
-
OPENTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006Citation Count: 462
-
OPENTitle: Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degenerationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1227End Page: 1231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.027Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.08.027Citation Count: 23
-
OPENTitle: Functional selectivity induced by mGlu4 receptor positive allosteric modulation and concomitant activation of Gq coupled receptorsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 122End Page: 132Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3412075Citation Count: 13
-
RESTRICTEDTitle: GBA‐associated parkinsonism and dementia: beyond α‐synucleinopathies?Journal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 3Start Page: 520End Page: 526Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12894Citation Count: 11